Influx Healthtech Board Approves Financial Results for FY 2026, Names New Internal Auditor
Influx Healthtech Limited announced that its Board of Directors held a meeting on May 20, 2026, where it considered and approved the standalone financial results for the half year and the full year ended March 31, 2026. The board also took note of the certificate regarding the utilization of issue proceeds and approved the appointment of a new Internal Auditor.Financial Results for FY 2026
The Board of Directors approved the audited standalone financial results for the period ending March 31, 2026, along with the accompanying audit reports.The company's standalone financial performance for the year ended March 31, 2026, showed strong figures:
| Particulars | For the year Ended March 31, 2026 (Rs. Lakhs) | For the year Ended March 31, 2025 (Rs. Lakhs) |
|---|---|---|
| Total Income | 14,816.85 | 10,498.67 |
| Total Expenses | 12,093.45 | 8,727.27 |
| Net Profit for the year | 2,054.13 | 1,327.31 |
| Basic Earnings per share (Rs.) | 9.35 | 7.31 |
For the half year ended March 31, 2026:
| Particulars | Half Year Ended March 31, 2026 (Rs. Lakhs) | Half Year Ended March 31, 2025 (Rs. Lakhs) |
|---|---|---|
| Total Income | 8,130.93 | 5,690.01 |
| Total Expenses | 6,714.76 | 4,688.79 |
| Net Profit for a period | 1,054.59 | 765.00 |
Balance Sheet Snapshot
The standalone balance sheet details as of March 31, 2026, showed an increase in total equity and liabilities compared to the previous year.| Particulars | As at March 31, 2026 (Rs. Lakhs) | As at March 31, 2025 (Rs. Lakhs) |
|---|---|---|
| Share Capital | 2,315.04 | 1,815.00 |
| Reserves and Surplus | 7,760.93 | 1,799.55 |
| Total Shareholders Fund | 10,075.97 | 3,614.55 |
| Total Non-Current Liabilities | 23.43 | 22.98 |
| Total Current Liabilities | 2,271.01 | 3,392.38 |
| Total Equity and Liabilities | 12,370.41 | 7,029.91 |
Cash Flow Activity (Year Ended March 31, 2026)
The company generated a net cash amount of 388.86 Rs. Lakhs from operating activities, with the overall net cash generated from operating activities reaching 388.86 Rs. Lakhs.| Activity Type | Amount (Rs. Lakhs) |
|---|---|
| Net Cash Generated from Operating Activities (A) | 388.86 |
| Net Cash used in Investment Activities (B) | (2,517.01) |
| Net cash generated from / (used in) Financing Activities (C) | 4,452.83 |
| Net Increase in Cash and Cash Equivalents (A+B+C) | 2,324.68 |
Corporate Governance and Compliance Updates
During the board meeting, the directors took note of the Certificate of Utilization of Issue Proceeds for the half year ended March 31, 2026.The company also announced the appointment of M/s. Phirodia bafna & Associates, Chartered Accountants, as the Internal Auditors for the financial year 2026-27.
The utilization of the initial public offering (IPO) proceeds totals are as follows:
| Object of Funds | Amount Disclosed in Offer Document (Rs. Lakhs) | Amount Utilized up to 31.03.2026 (Rs. Lakhs) | Unutilized Amount (Rs. Lakhs) |
|---|---|---|---|
| Funding CapEx (Manufacturing Facilities) | 3,673.34 | 1,384.15 | 2,289.19 |
| General Corporate Purpose | 667.40 | 667.40 | - |
| Public Issue Expenses | 583.24 | 583.24 | - |
| Total | 4,923.98 | 2,634.79 | 2,289.19 |
INFLUX Stock Price Movement
Today, Influx Healthtech Limited shares edged higher to close at ₹279.4, gaining 0.81% in post-market trading. The stock saw 14,400 shares traded today, maintaining a narrow intraday range between ₹274 and ₹279.9.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: